CDT
CDT Equity Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.63
−16.56%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 0.01x
- PEG TTM
- —
- Price / book
- 0.01x
- Price / sales
- 0.01x
- Price / cash flow
- 0.07x
Enterprise value
- Enterprise value
- $979.1M
- EV / sales
- 0.68x
- EV / EBITDA
- 4.02x
- EV / EBIT
- 5.86x
- Market cap
- $8.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026